C
Merck & Co., Inc. MRK
$113.44 $1.070.95% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Net Income -183.48% -20.84% 83.24% -18.85% 6.66%
Total Depreciation and Amortization 32.70% 27.29% -4.19% -0.19% 15.13%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 11,056.00% 77.46% -115.59% -52.34% -90.52%
Change in Net Operating Assets 56.55% -25.01% -49.11% -123.22% -9.76%
Cash from Operations 56.72% -17.19% -15.81% -41.58% -19.09%
Capital Expenditure 25.38% -10.25% -26.05% 3.41% -54.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -502,000.00% -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -176.73% 75.05% 148.76% 97.84% -168.83%
Cash from Investing -586.62% -675.69% 92.64% 27.97% -8.07%
Total Debt Issued -- -- 597,800.00% -98.67% --
Total Debt Repaid 54.40% 99.63% -- -- -232.89%
Issuance of Common Stock 726.32% 291.67% 180.00% -83.56% -78.16%
Repurchase of Common Stock 24.91% -156.03% -197.97% -435.86% -854.10%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -2.68% -3.43% -3.99% -4.58% -5.13%
Other Financing Activities -33.33% 388.10% 106.25% 11.82% 23.08%
Cash from Financing 48.20% 257.89% 208.78% -392.43% -104.51%
Foreign Exchange rate Adjustments -112.18% 106.27% -96.60% 556.10% 213.04%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -102.62% -160.58% 207.30% -111.56% -270.44%